Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01401348 · ClinicalTrials.gov registry record
Stanford Universities: The Stanford HIV Aging Cohort
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 154
- Enrollment target
NCT01401348: Completed study, sponsored by Stanford University.
NCT01401348 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 154 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01401348 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 154 participants
- Enrollment target
Study Summary
A research study to evaluate the effect of aging and HIV on neurocognitive dysfunction (declining ability to process information), physical frailty and heart disease. HIV-infected participants whose virus is controlled on antiretroviral medications will be studied to determine the rates and risk factors of developing these conditions.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 154 participants |
| Start Date | 2010-12 |
| Est. Completion | 2015-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01401348
The ClinicalTrials.gov registry entry for NCT01401348 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 154 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01401348 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01401348 about?
NCT01401348 is a clinical study titled "Stanford Universities: The Stanford HIV Aging Cohort". A research study to evaluate the effect of aging and HIV on neurocognitive dysfunction (declining ability to process information), physical frailty and heart disease. HIV-infected participants whose virus is controlled on antiretroviral medications will be studied to determine the rates and risk fac...
What is the current status of trial NCT01401348?
This trial is currently completed. The enrollment target is 154 participants. The study started on 2010-12. Estimated completion is 2015-12.
Who is sponsoring clinical trial NCT01401348?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.